Scarica l'app Stockscreener
7.77
0.65%
0.05
Precedente Chiudi:
$7.72
Aprire:
$7.72
Volume 24 ore:
2,004
Relative Volume:
0.31
Capitalizzazione di mercato:
$9.57M
Reddito:
$630.00K
Utile/perdita netta:
$5.72M
Rapporto P/E:
-22.75
EPS:
-0.3415
Flusso di cassa netto:
$-6.75M
1 W Prestazione:
+0.91%
1M Prestazione:
-5.59%
6M Prestazione:
-2.88%
1 anno Prestazione:
+10.06%
Intervallo 1D:
$7.68
$7.89
Intervallo di 1 settimana:
$7.40
$8.00
Portata 52W:
$6.51
$12.05
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
Nome
Addex Therapeutics Ltd Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare ADXN vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
7.77 | 9.51M | 630.00K | 5.72M | -6.75M | -0.3415 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-31 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr Borsa (ADXN) Ultime notizie
Addex publishes negative allosteric modulators data in Molecular Psychiatry - TipRanks
CGX Energy (CVE:OYL) Shares Up 17.2% – Should You Buy? - Defense World
Paycom Software (NYSE:PAYC) Price Target Lowered to $210.00 at UBS Group - Defense World
Addex Therapeutics earnings call: Progress amidst financial challenges - MSN
Addex Therapeutics Earnings Call: Progress Amidst Financial Challenges - TipRanks
Addex Therapeutics Reports Q3 2025 Financial Results - TipRanks
Earnings call transcript: Addex Therapeutics Q3 2025 sees stock dip post-earnings By Investing.com - Investing.com South Africa
Earnings call transcript: Addex Therapeutics Q3 2025 sees stock dip post-earnings - Investing.com India
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Total debt per share of Addex Therapeutics Ltd Sponsored ADR – MUN:APE1 - TradingView
Addex Therapeutics (NASDAQ:ADXN) Stock Price Down 5.5% – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
How geopolitical risks impact Addex Therapeutics Ltd (APE) stockShare Buyback & Consistent Growth Equity Picks - newser.com
[F-3] Addex Therapeutics Ltd. Foreign Issuer Shelf Registration | ADXN SEC FilingForm F-3 - Stock Titan
Why Addex Therapeutics Ltd (APE) stock stays on buy listsJuly 2025 Weekly Recap & Weekly High Potential Alerts - newser.com
Short Interest in Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Grows By 61.0% - Defense World
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Short Interest Down 91.1% in September - Defense World
Revenue per share of Addex Therapeutics Ltd Sponsored ADR – BER:APE1 - TradingView
Addex Therapeutics Earnings Call: Strategic Gains Amid Challenges - MSN
Addex Therapeutics (NASDAQ:ADXN) Shares Up 5.6% – Here’s What Happened - Defense World
Addex Therapeutics’ (ADXN) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - Defense World
Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Sees Significant Increase in Short Interest - Defense World
Addex Therapeutics Reports Significant Loss Amid Financial Challenges - TipRanks
Addex Therapeutics H1 2025 Earnings Call Transcript - MarketBeat
Will V.F. Corporation (VFP) stock see valuation expansionExit Point & AI Driven Stock Movement Reports - newser.com
Addex Therapeutics (NASDAQ:ADXN) Shares Down 6.5% – What’s Next? - Defense World
Lion Group (NASDAQ:LGHL) Stock Price Down 4.3% – Here’s Why - Defense World
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - MSN
Can trapped investors hope for a rebound in Vine Hill Capital Investment Corp.Quarterly Profit Report & Pattern Based Trade Signal System - newser.com
Applying sector rotation models to Quipt Home Medical Corp.Portfolio Profit Report & Expert Verified Stock Movement Alerts - newser.com
Is This The Best Time To Buy iSpecimen Inc (NASDAQ: ISPC) Stock? - stocksregister.com
How to read the order book for Addex Therapeutics Ltd Depositary ReceiptInsider Buying & Long Hold Capital Preservation Plans - Newser
What earnings revisions data tells us about Core Scientific Inc.Earnings Summary Report & Daily Stock Momentum Reports - Newser
Strategies to average down on Addex Therapeutics Ltd Depositary ReceiptPortfolio Return Report & Weekly High Conviction Trade Ideas - Newser
Should you hold or exit SONY nowExit Point & Intraday High Probability Setup Alerts - Newser
Can trapped investors hope for a rebound in Titan Machinery Inc.Earnings Recap Summary & AI Enhanced Execution Alerts - Newser
ADR Ratio Change - Yahoo
Addex Therapeutics Reports Q1 2025 Financial Results - TipRanks
Addex Therapeutics Ltd Stock Price Today | NASDAQ: ADXN Live - Investing.com
European Equities See Growth In US ADR Market - Finimize
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Nasdaq
Addex Stock Soars on Crucial Update From Indivior Research Deal - Yahoo Finance
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Is Alcon (ALC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Addex Therapeutics (ADXN) Stock Forecast and Price Target 2025 - MarketBeat
Earnings call: Addex Therapeutics reports on collaborations and financials - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
What is the current Price Target and Forecast for Addex Therapeutics (ADXN) - Zacks Investment Research
Addex Therapeutics Ltd Adr Azioni (ADXN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):